外科用シーラント及び接着剤の世界市場：天然接着剤、合成接着剤、フィブリン組織、コラーゲン、ゼラチン、シアノアクリレート、重合体、ポリウレタン...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 22
1.5 STAKEHOLDERS 22

2 RESEARCH METHODOLOGY 23
2.1 RESEARCH APPROACH 23
2.1.1 SECONDARY DATA 24
2.1.1.1 Key data from secondary sources 24
2.1.2 PRIMARY DATA 25
2.1.2.1 Key data from primary sources 25
2.1.2.2 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 27
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 29
2.4 MARKET SHARE ESTIMATION 30
2.5 RESEARCH ASSUMPTIONS 30
2.5.1 ASSUMPTIONS FOR THE STUDY 30

3 EXECUTIVE SUMMARY 31

4 PREMIUM INSIGHTS 36
4.1 SURGICAL SEALANTS AND ADHESIVES MARKET OVERVIEW 36
4.2 ASIA-PACIFIC SURGICAL SEALANTS AND ADHESIVES MARKET: BY PRODUCT 36
4.3 SURGICAL SEALANTS AND ADHESIVES MARKET: GEOGRAPHIC SNAPSHOT 37
4.4 SURGICAL SEALANTS AND ADHESIVES MARKET: BY REGION 38
4.5 SURGICAL SEALANTS AND ADHESIVES MARKET SHARE: BY PRODUCT 38

5 MARKET OVERVIEW 39
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 41
5.3 KEY MARKET DRIVERS 42
5.3.1 GROWING NEED TO MANAGE BLOOD LOSS IN PATIENTS 42
5.3.2 RISING NUMBER OF SURGICAL PROCEDURES ACROSS THE GLOBE 42
5.3.3 GREATER UPTAKE OF TECHNOLOGICALLY ADVANCED PRODUCTS 43
5.3.4 FDA AND CE MARK APPROVALS DRIVING ADOPTION OF SURGICAL SEALANTS AND ADHESIVES 43
5.4 KEY MARKET RESTRAINTS 45
5.4.1 LACK OF REIMBURSEMENTS FOR SURGICAL SEALANTS AND ADHESIVES 45
5.4.2 HIGH COSTS AND CLINICAL DATA REQUIREMENTS FOR LAUNCHING NEW PRODUCTS 45
5.5 KEY MARKET OPPORTUNITIES 46
5.5.1 EMERGING MARKETS 46
5.6 KEY CHALLENGES 47
5.6.1 DEVELOPMENT OF NOVEL BIOMATERIALS WITH HIGH MECHANICAL PROPERTIES AND HIGH ADHESION STRENGTH 47
5.6.2 NEED OF SKILLED PERSONNEL FOR THE EFFECTIVE USE OF SURGICAL SEALANTS AND ADHESIVES 47

6 INDUSTRY INSIGHTS 49
6.1 INTRODUCTION 49
6.2 INDUSTRY TRENDS 49
6.2.1 GROWING PREFERENCE FOR GELATIN-BASED ADHESIVES AND POLYMERIC HYDROGELS IN SURGICAL PROCEDURES 49
6.2.2 INCREASING NUMBER OF ACQUISITIONS DRIVING CONSOLIDATION IN THE MARKET 50
6.3 PORTER’S FIVE FORCES ANALYSIS 50
6.3.1 THREAT OF NEW ENTRANTS 51
6.3.2 THREAT OF SUBSTITUTES 51
6.3.3 BARGAINING POWER OF SUPPLIERS 52
6.3.4 BARGAINING POWER OF BUYERS 52
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 53
6.4 STRATEGIC BENCHMARKING 53
6.4.1 PRODUCT PORTFOLIO ANALYSIS: SURGICAL SEALANTS AND ADHESIVES MARKET 54

7 SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT 56
7.1 INTRODUCTION 57
7.2 NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES 58
7.2.1 NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES, BY TYPE 59
7.2.1.1 Fibrin sealants 60
7.2.1.2 Collagen-based Adhesives 61
7.2.1.3 Gelatin-based Adhesives 62
7.2.2 NATURAL/BIOLOGICAL SEALANTS AND ADHESIVES, BY ORIGIN 64
7.2.2.1 Human Blood-based 65
7.2.2.2 Animal-based adhesives and sealants 66
 
7.3 SYNTHETIC AND SEMISYNTHETIC ADHESIVES AND SEALANTS 67
7.3.1 CYANOACRYLATES 69
7.3.2 POLYMERIC HYDROGELS 70
7.3.3 URETHANE-BASED ADHESIVES 72

8 SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
8.2 CENTRAL NERVOUS SYSTEM (CNS) SURGERIES 75
8.3 GENERAL SURGERIES (LIVER, GASTROINTESTINAL, PANCREATIC, SPLEEN SURGERIES, HERNIA REPAIR) 77
8.4 CARDIOVASCULAR SURGERIES 78
8.5 ORTHOPEDIC SURGERIES 80
8.6 COSMETIC SURGERIES 82
8.7 UROLOGICAL SURGERIES 83
8.8 OPHTHALMIC SURGERIES 84
8.9 PULMONARY SURGERIES 86
8.10 OTHER APPLICATIONS 87

9 GEOGRAPHIC ANALYSIS 89
9.1 INTRODUCTION 90
9.2 NORTH AMERICA 91
9.2.1 U.S. 95
9.2.2 CANADA 98
9.3 EUROPE 101
9.3.1 GERMANY 105
9.3.2 FRANCE 108
9.3.3 U.K. 111
9.3.4 ITALY 113
9.3.5 SPAIN 116
9.3.6 REST OF EUROPE 118
9.4 ASIA-PACIFIC 121
9.4.1 JAPAN 125
9.4.2 CHINA 128
9.4.3 INDIA 131
9.4.4 REST OF ASIA-PACIFIC 133
9.5 REST OF THE WORLD (ROW) 136
9.5.1 LATIN AMERICA 138
9.5.2 MIDDLE EAST AND AFRICA 141
 
10 COMPETITIVE LANDSCAPE 144
10.1 OVERVIEW 144
10.2 MARKET SHARE ANALYSIS 145
10.3 COMPETITIVE SITUATION AND TRENDS 147
10.3.1 REGULATORY APPROVALS 148
10.3.2 MERGERS AND ACQUISITIONS 149
10.3.3 AGREEMENTS AND COLLABORATIONS 150
10.3.4 EXPANSIONS 151
10.3.5 NEW PRODUCT LAUNCHES 152
10.3.6 OTHERS 152

11 COMPANY PROFILES 153
11.1 INTRODUCTION 153
11.2 BAXTER INTERNATIONAL, INC. 154
11.2.1 BUSINESS OVERVIEW 154
11.2.2 PRODUCT OFFERINGS 155
11.2.3 RECENT DEVELOPMENTS 155
11.2.4 MNM VIEW 155
11.3 JOHNSON & JOHNSON (ETHICON, INC.) 156
11.3.1 BUSINESS OVERVIEW 156
11.3.2 PRODUCT OFFERINGS 157
11.3.3 RECENT DEVELOPMENTS 157
11.3.4 MNM VIEW 157
11.4 MEDTRONIC PLC 158
11.4.1 BUSINESS OVERVIEW 158
11.4.2 PRODUCT OFFERINGS 159
11.4.3 RECENT DEVELOPMENTS 159
11.4.4 MNM VIEW 160
11.5 CRYOLIFE, INC. 161
11.5.1 BUSINESS OVERVIEW 161
11.5.2 PRODUCT OFFERINGS 162
11.5.3 RECENT DEVELOPMENTS 162
11.5.4 MNM VIEW 162
11.6 C.R. BARD, INC. 163
11.6.1 BUSINESS OVERVIEW 163
11.6.2 PRODUCT OFFERINGS 164
11.6.3 RECENT DEVELOPMENTS 164
11.6.4 MNM VIEW 164
11.7 SANOFI GROUP 165
11.7.1 BUSINESS OVERVIEW 165
11.7.2 PRODUCT OFFERINGS 166
11.7.3 RECENT DEVELOPMENTS 166
11.8 B. BRAUN MELSUNGEN AG 167
11.8.1 BUSINESS OVERVIEW 167
11.8.2 PRODUCT OFFERINGS 168
11.8.3 RECENT DEVELOPMENTS 168
11.9 COHERA MEDICAL INC. 169
11.9.1 BUSINESS OVERVIEW 169
11.9.2 FINANCIALS 169
11.9.3 PRODUCT OFFERINGS 169
11.9.4 RECENT DEVELOPMENTS 169
11.10 OCULAR THERAPEUTIX, INC. 170
11.10.1 BUSINESS OVERVIEW 170
11.10.2 FINANCIALS 170
11.10.3 PRODUCT OFFERINGS 170
11.10.4 RECENT DEVELOPMENTS 170
11.11 VIVOSTAT A/S 171
11.11.1 BUSINESS OVERVIEW 171
11.11.2 FINANCIALS 171
11.11.3 PRODUCT OFFERINGS 171
11.11.4 RECENT DEVELOPMENTS 171

12 APPENDIX 172
12.1 INSIGHTS OF INDUSTRY EXPERTS 172
12.2 DISCUSSION GUIDE 173
12.3 OTHER DEVELOPMENTS 177
12.4 AVAILABLE CUSTOMIZATIONS 177
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 178
12.6 RELATED REPORTS 180